What Instituto Nacional de Salud does

Instituto Nacional de Salud (INS) is Peru's principal national public health research institution, founded in 1896 and operating under the Ministry of Health (Ministerio de Salud, MINSA). It functions as a state-owned technical arm of the Peruvian government, executing disease surveillance, laboratory reference services, health technology assessment, food and pharmaceutical quality control, biological production (including antivenoms via CNPB), and public health research through ten national centers: CENAN (nutrition), CNCC (quality control), CENSI (social and intercultural health), CNPB (biological production), CENSOPAS (occupational health), CNSP (public health), CETS (health technology evaluation), DIIS (research and innovation), DISAP (public health direction), and OPPM (planning and budgeting). Headcount stands at 1,717 employees.

Its core technology footprint is a multi-platform government digital infrastructure rather than a commercial product stack. This includes Netlab v1.0 and v2.0 for laboratory information management across the public health system; a Repositorio Científico with more than 1,500 open-access publications spanning 12 research communities; the Allin Kawsay bilingual (Spanish-Quechua) clinical communication platform with offline mobile capabilities for indigenous populations; thematic public health portals (nutrition, anemia, obesity observatory, drug prevention); and a pharmacovigilance system. The Allin Kawsay tool, developed with Universidad Nacional Mayor de San Marcos (UNMSM), represents a distinctive intercultural health innovation.

INS's business model is non-commercial: it is fully funded through the Peruvian national budget via MINSA, with no publicly disclosed user fees or commercial revenue. Services are delivered through a national laboratory network linking regional health directorates (DIRESA/DISA), the RENETSA health technology evaluation network, and digital self-serve channels for citizens. Customer segments are effectively the Peruvian population, government health entities, regulated food and pharmaceutical industries, and Quechua-speaking indigenous communities. Recent strategic activity includes a July 2026 cross-border cooperation agreement with Bolivia's Ministry of Health and ongoing capacity-building partnerships with ENSAP.

Name

Instituto Nacional de Salud

Legal name

Instituto Nacional de Salud

Website

https://ins.gob.pe

Company type

Private

Founded year

1896

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Instituto Nacional de Salud (INS) is Peru's principal national public health research institution, founded in 1896 and operating under the Ministry of Health (MINSA). It runs disease surveillance, laboratory reference services, health technology assessment, and quality control through ten national centers serving the Peruvian population, regional health directorates, and indigenous Quechua-speaking communities.

Ownership category

akta.pro rank

Product category

Public Health Research Services

NAICS

Administration of Public Health Programs (92312), Public Administration (92)

SIC

Services-Health Services (8000), In Vitro & In Vivo Diagnostic Substances (2835), Pharmaceutical Preparations (2834)

akta.pro primary industry

Data Integration, Interoperability & Reporting (ELR/HIE/CDC/NNDSS) (HLAJABAN)

akta.pro secondary industries

Public Health & Immunization Data Exchange (ELR, case reporting, registry reporting) (HLACABAL), Health Systems Strengthening & Global Health Technical Assistance (BPADAEAH), Quality Management & Regulatory Compliance (CLIA/CAP/ISO) for Labs (HLACAMAH), Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)

Keywords

• Public health research
• Disease surveillance services
• Health technology assessment
• Laboratory reference services
• Pharmaceutical quality control

Headquarters

HQ city

Lima

HQ country

Peru

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Distribution channels3 records

Marketing channels6 records

Core offering

The Instituto Nacional de Salud (INS) is Peru's national public health research institution operating under the Ministry of Health (MINSA). It delivers laboratory reference services, disease surveillance, health technology assessment, pharmaceutical and food quality control, and operates a portfolio of digital platforms including the bilingual Allin Kawsay tool, Netlab laboratory information systems, open-access scientific repositories, and COVID-19 diagnostic portals serving the Peruvian population and national health system.

Product overview

The Instituto Nacional de Salud operates a multi-platform digital portfolio consisting of core public health systems and web/mobile applications. The flagship product is Allin Kawsay, a bilingual (Spanish-Quechua) clinical communication platform enabling healthcare professionals to serve indigenous populations through offline-capable mobile and web interfaces. Supporting infrastructure includes Netlab (v1.0 and v2.0) for laboratory information management, the Repositorio Científico for open-access scientific publications, and the Sistema de Gestión Documental for administrative workflows. Thematic web portals address specific public health priorities including nutrition (CENAN), anemia, healthy eating, obesity surveillance, and drug prevention. Mobile applications extend access to Quechua-language health services. The platform operates across web, mobile (Android), and institutional intranet channels, with no commercial product pricing as this is a government public health institution.

Differentiator

Problem solved

Functional benefit

Brands

• INS: Abbreviated name for Instituto Nacional de Salud used in official communications and branding.

Products and services

• Allin Kawsay Bilingual (Spanish-Quechua) digital clinical communication platform enabling healthcare professionals to conduct clinical interviews, physical examinations, diagnostic tests, treatments, and referrals with Quechua-speaking patients, including offline mobile access. Developed in collaboration with UNMSM.
• Repositorio Científico INS Open-access digital institutional repository hosting scientific publications, research reports, and technical documents from INS centers including CETS, CNSP, CENAN, CNPB, CENSOPAS, and others, available to researchers and the public.
• Netlab v1.0 y v2.0

Quantifiable outcome

• 130 years of institutional service to Peruvian public health
• +2 more outcomes

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Five partnerships are on record, tiered minor and core.

• Escuela Nacional de Salud Pública (ENSAP)minorStrategic or Co-development Partner · 14 July 2026ENSAP and INS jointly inaugurated a training course for public health educators and leaders, strengthening human resource capacity in the national health system.
• Bolivia (Ministry of Health)minorStrategic or Co-development Partner · 2 July 2026INS is sharing Peruvian scientific experience and knowledge with Bolivia to help face diseases and environmental health risks. This international cooperation involves cross-border health collaboration in the Andean region.
• National Health Technology Evaluation Network (RENETSA)coreStrategic or Co-development PartnerRENETSA is the national network through which INS's Centro de Evaluación de Tecnologías en Salud (CETS) coordinates health technology assessments across Peru, producing evaluations for the national health system.
• DIRESA/DISA (Regional Health Directorates)coreStrategic or Co-development PartnerRegional health directorates throughout Peru collaborate with INS for laboratory reference services, epidemiological surveillance, and implementation of public health programs.
• Universidad Nacional Mayor de San MarcosminorStrategic or Co-development PartnerThe Allin Kawsay tool was developed using the Quechua clinical history annex from the book 'Guía para una Historia Clínica' by Dr. Cesar Cabezas Sánchez, Professor at UNMSM. Dr. César Cabezas Sánchez contributed to the development of this intercultural health tool.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Centers for Disease Control and Prevention (CDC): The U.S. CDC is the global gold standard for national public health institutes, performing disease surveillance, laboratory reference services, and health technology assessment at scale. Comparable to INS in core functions (epidemiology, lab network, outbreak response), though CDC operates with materially larger budget and global footprint.
• UK Health Security Agency (UKHSA): UKHSA is the UK's national public health agency responsible for health protection, infectious disease surveillance, and laboratory reference services. Comparable to INS in mandate scope (disease surveillance, lab reference, emergency response), though operating at substantially greater scale and digital maturity.
• Robert Koch Institute (RKI): Germany's RKI is the federal government agency for disease surveillance, biomedical analysis, and public health research. Comparable to INS in core mandate (epidemiology, lab reference, health protection), though at materially larger scale and with deeper genomic surveillance infrastructure.
• National Institutes of Health (NIH): The U.S. NIH is a federal agency conducting and supporting biomedical and public health research across a vast portfolio of institutes. Comparable to INS in the research and innovation dimension (DIIS), though NIH operates at vastly greater scale, with research funding mechanisms INS does not have access to.
• Pan American Health Organization (PAHO): PAHO serves as the regional coordinating body for national public health institutes across the Americas. INS is a counterpart institution that PAHO engages with for cross-border surveillance, laboratory networks, and technical cooperation — making PAHO both a partner and the regional entity that frames INS's international role.

Direct peers

• Fundação Oswaldo Cruz (Fiocruz): Brazil's Fiocruz is the closest functional peer to INS: a national public health institute under Brazil's Ministry of Health, conducting disease surveillance, laboratory reference work, biological production (including vaccines), and health technology assessment. The shared Latin American public health system structure makes Fiocruz the most directly comparable peer.
• Instituto Nacional de Salud (Colombia): Colombia's INS shares an identical name and mandate, operating as the national public health reference institute under the Colombian Ministry of Health. Performs disease surveillance, laboratory reference, and public health research functions structurally parallel to Peru's INS, and is a natural bilateral cooperation peer.
• Instituto Nacional de Salud Pública (INSP, Mexico): Mexico's INSP is a national public health research and training institution performing disease surveillance, health systems research, and public health laboratory functions. Comparable to INS in mandate and operational structure, with similar scope in nutrition surveillance and health technology assessment.

Emerging players

• China CDC (Chinese Center for Disease Control and Prevention): China CDC is the national public health agency performing disease surveillance, outbreak response, and laboratory reference across China. Structurally analogous to INS, though operating at far larger scale and with rapidly developed genomic surveillance capabilities that benchmark emerging global standards.

Others

• Health Technology Assessment International (HTAi): HTAi is the global professional society for health technology assessment, the function INS's CETS center performs for RENETSA. Comparable because CETS operates as Peru's national HTA body, and HTAi provides the methodological framework, peer network, and international standards that govern CETS's evaluations.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/instituto-nacional-de-salud

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Instituto Nacional de Salud